Renowned infectious diseases specialist and Deputy Chief Health Officer, Associate Professor Dan O’Brien, will be the key speaker at Western Victoria PHN’s (WVPHN) upcoming COVID-19 Anti-viral Prescribing information and question and answer session on 24 May.
Dr O’Brien will speak at the online session alongside WVPHN’s Clinical Lead Dr Kate Graham to provide GPs and other primary health care staff with essential information on prescribing COVID-19 anti-viral medications. The session is being held in conjunction with the Barwon South-West and Grampians Public Health Units (PHUs). It will include a panel discussion with representatives from both PHUs and a UFS pharmacist.
Dr O’Brien is currently Deputy Director of the Department of Infectious Diseases at University Hospital, Geelong and a Clinical Associate Professor in the Victorian Infectious Diseases Service and Department of Medicine (University of Melbourne) at The Royal Melbourne Hospital, Melbourne, Australia. He is also Victoria’s Deputy Chief Health Officer working in the COVID-19 response.
His attendance at the information session will offer primary health care clinicians valuable insight into assessing patients when prescribing the oral anti-viral therapies, Lagevrio and Paxlovid.
The session will also provide guidance on pathways for accessing the anti-viral medications and what clinical support is available to general practices within western Victoria. Attendees can also submit questions in advance to the panel discussion.
The online session is part of WVPHN’s ongoing training and support program for assisting health care professionals in our region respond to COVID-19